Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases.
作者信息
Shao Zhuo, Wang Zhongxiao, Lo Amy C Y, Fu Zhongjie
机构信息
Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
出版信息
Front Pharmacol. 2021 Apr 15;12:657684. doi: 10.3389/fphar.2021.657684. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases.社论：神经血管性视网膜疾病的新型治疗靶点与药物研发
Front Pharmacol. 2021 Apr 15;12:657684. doi: 10.3389/fphar.2021.657684. eCollection 2021.
2
New insights into the retinal circulation: inflammatory lipid mediators in ischemic retinopathy.视网膜循环的新见解：缺血性视网膜病变中的炎性脂质介质。
Prostaglandins Leukot Essent Fatty Acids. 2005 May;72(5):301-25. doi: 10.1016/j.plefa.2005.02.004.
3
Review of the mechanisms and therapeutic avenues for retinal and choroidal vascular dysfunctions in retinopathy of prematurity.早产儿视网膜病变中视网膜和脉络膜血管功能障碍的机制及治疗途径综述
Acta Paediatr. 2016 Dec;105(12):1421-1433. doi: 10.1111/apa.13586. Epub 2016 Sep 28.
4
The neurovascular unit and the pathophysiologic basis of diabetic retinopathy.神经血管单元与糖尿病视网膜病变的病理生理基础
Graefes Arch Clin Exp Ophthalmol. 2017 Jan;255(1):1-6. doi: 10.1007/s00417-016-3548-y. Epub 2016 Nov 10.
5
The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization.低氧诱导因子-1拮抗剂吖啶黄素：在视网膜中的可视化及对眼部新生血管形成的抑制作用
J Mol Med (Berl). 2017 Apr;95(4):417-429. doi: 10.1007/s00109-016-1498-9. Epub 2016 Dec 21.
6
Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.糖尿病视网膜病变中的神经血管相互作用：病理生理作用及治疗意义
Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H738-49. doi: 10.1152/ajpheart.00005.2016. Epub 2016 Jul 29.
7
RORα modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis.RORα调节病理性视网膜血管生成中的信号素3E转录和神经血管相互作用。
FASEB J. 2017 Oct;31(10):4492-4502. doi: 10.1096/fj.201700172R. Epub 2017 Jun 23.
8
Inflammatory lipid mediators in ischemic retinopathy.缺血性视网膜病变中的炎症脂质介质。
Pharmacol Rep. 2005;57 Suppl:169-90.
9
The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target.视网膜新生血管形成中的尿激酶/尿激酶受体系统：A6的抑制作用提示了一个新的治疗靶点。
Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2736-42. doi: 10.1167/iovs.02-1160.
10
MicroRNA-18a-5p Administration Suppresses Retinal Neovascularization by Targeting FGF1 and HIF1A.通过靶向FGF1和HIF1A，施用MicroRNA - 18a - 5p可抑制视网膜新生血管形成。
Front Pharmacol. 2020 Mar 10;11:276. doi: 10.3389/fphar.2020.00276. eCollection 2020.
本文引用的文献
1
Neutrophil extracellular traps target senescent vasculature for tissue remodeling in retinopathy.中性粒细胞胞外诱捕网靶向衰老血管以实现视网膜病变中的组织重塑。
Science. 2020 Aug 21;369(6506). doi: 10.1126/science.aay5356.
2
The metabolic engine of endothelial cells.内皮细胞的代谢引擎。
Nat Metab. 2019 Oct;1(10):937-946. doi: 10.1038/s42255-019-0117-9. Epub 2019 Sep 30.
3
Targeting Neurovascular Interaction in Retinal Disorders.靶向视网膜疾病中的神经血管相互作用。
Int J Mol Sci. 2020 Feb 22;21(4):1503. doi: 10.3390/ijms21041503.
4
Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy.黄斑病变和外周神经病中的丝氨酸和脂质代谢。
N Engl J Med. 2019 Oct 10;381(15):1422-1433. doi: 10.1056/NEJMoa1815111. Epub 2019 Sep 11.
5
Dyslipidemia in retinal metabolic disorders.视网膜代谢紊乱中的血脂异常。
EMBO Mol Med. 2019 Oct;11(10):e10473. doi: 10.15252/emmm.201910473. Epub 2019 Sep 5.
6
MicroRNA expression profile in retina and choroid in oxygen-induced retinopathy model.在氧诱导视网膜病变模型中视网膜和脉络膜的 microRNA 表达谱。
PLoS One. 2019 Jun 12;14(6):e0218282. doi: 10.1371/journal.pone.0218282. eCollection 2019.
7
MicroRNA-384-3p inhibits retinal neovascularization through targeting hexokinase 2 in mice with diabetic retinopathy.微小 RNA-384-3p 通过靶向糖尿病视网膜病变小鼠中的己糖激酶 2 抑制视网膜新生血管形成。
J Cell Physiol. 2018 Jan;234(1):721-730. doi: 10.1002/jcp.26871. Epub 2018 Sep 7.
8
The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy.抗血管内皮生长因子（抗VEGF）在增殖性糖尿病视网膜病变治疗中的作用。
Drugs Context. 2018 Aug 13;7:212532. doi: 10.7573/dic.212532. eCollection 2018.
9
Safety and Efficacy of Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration: A Report by the American Academy of Ophthalmology.抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性的安全性和疗效：美国眼科学会报告。
Ophthalmology. 2019 Jan;126(1):55-63. doi: 10.1016/j.ophtha.2018.07.028. Epub 2018 Aug 2.
10
SWATH-MS Proteomic Analysis of Oxygen-Induced Retinopathy Reveals Novel Potential Therapeutic Targets.SWATH-MS 蛋白质组学分析氧诱导性视网膜病变揭示新的潜在治疗靶点。
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3294-3306. doi: 10.1167/iovs.18-23831.
Zotero 插件